AstraZeneca COVID-19 vaccine applies for full regulatory approval in Brazil


  • World
  • Saturday, 30 Jan 2021

FILE PHOTO: A test tube labelled "vaccine" in front of an AstraZeneca logo in this illustration taken, September 9, 2020. REUTERS/Dado Ruvic/Illustration/File Photo

RIO DE JANEIRO (Reuters) - Brazilian health regulator Anvisa said on Friday that a COVID-19 vaccine developed by Oxford University and AstraZeneca Plc had applied for full regulatory approval, in a positive development for the country's beleaguered vaccine rollout.

The submission, the first of its kind in Brazil, was made by the federally funded Fiocruz Institute, which will manufacture the British vaccine locally. A spokeswoman for AstraZeneca, whose vaccine is already approved for emergency use in Brazil, confirmed the submission.

Subscribe now and receive FREE sooka plan for 1 month.
T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In World

Buy now, pay later: Latin America pressured by Chinese online shops
Amazon launches an online discount storefront to better compete with Shein and Temu
South Korea top court upholds conviction of 'comfort women' activist over embezzlement
Australia to make big tech liable for citizens’ online safety
New Zealand parliament debates controversial bill as protesters march on capital
Philippines Marcos' says will not block ICC if ex-president Duterte wants to be investigated
Cross-border challenges widen wealth gap between Europe and US, IMF study finds
Trump taps firebrand congressman Matt Gaetz for attorney general
Bob Lee’s accused killer says tech executive ‘went crazy on me’
Think twice before sharing photos of your kids online, experts say

Others Also Read